DEA
RMD icon

DoubleLine ETF Adviser’s ResMed RMD Stock Holding History

DoubleLine ETF Adviser’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Buy
+1,782
New +$444K 0.15% 130

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DoubleLine ETF Adviser's RMD Position: Q1 2026 in Review

DoubleLine ETF Adviser opened a new position in ResMed (RMD) in Q1 2026: 1,782 shares worth $400K. The stake represents 0.15% of the portfolio and ranks #130 among its holdings.

938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • DoubleLine ETF Adviser held 1,782 shares of ResMed worth $400K as of Q1 2026.
  • ResMed was a new DoubleLine ETF Adviser position in Q1 2026.
  • ResMed made up 0.15% of DoubleLine ETF Adviser's portfolio in Q1 2026, its #130 holding.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.